These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1140 related articles for article (PubMed ID: 27068264)

  • 41. Selective ORAI1 Inhibition Ameliorates Autoimmune Central Nervous System Inflammation by Suppressing Effector but Not Regulatory T Cell Function.
    Kaufmann U; Shaw PJ; Kozhaya L; Subramanian R; Gaida K; Unutmaz D; McBride HJ; Feske S
    J Immunol; 2016 Jan; 196(2):573-85. PubMed ID: 26673135
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Gpr97/Adgrg3 ameliorates experimental autoimmune encephalomyelitis by regulating cytokine expression.
    Wang J; Wang X; Chen X; Lu S; Kuang Y; Fei J; Wang Z
    Acta Biochim Biophys Sin (Shanghai); 2018 Jul; 50(7):666-675. PubMed ID: 29860267
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Infiltration of Th1 and Th17 cells and activation of microglia in the CNS during the course of experimental autoimmune encephalomyelitis.
    Murphy AC; Lalor SJ; Lynch MA; Mills KH
    Brain Behav Immun; 2010 May; 24(4):641-51. PubMed ID: 20138983
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A novel human truncated IL12rβ1-Fc fusion protein ameliorates experimental autoimmune encephalomyelitis via specific binding of p40 to inhibit Th1 and Th17 cell differentiation.
    Guo W; Wang C; Wang X; Luo C; Yu D; Wang Y; Chen Y; Lei W; Gao X; Yao W
    Oncotarget; 2015 Oct; 6(30):28539-55. PubMed ID: 26384304
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Invariant NKT cells producing IL-4 or IL-10, but not IFN-gamma, inhibit the Th1 response in experimental autoimmune encephalomyelitis, whereas none of these cells inhibits the Th17 response.
    Oh SJ; Chung DH
    J Immunol; 2011 Jun; 186(12):6815-21. PubMed ID: 21572032
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Absence of Notch1 in murine myeloid cells attenuates the development of experimental autoimmune encephalomyelitis by affecting Th1 and Th17 priming.
    Fernández M; Monsalve EM; López-López S; Ruiz-García A; Mellado S; Caminos E; García-Ramírez JJ; Laborda J; Tranque P; Díaz-Guerra MJM
    Eur J Immunol; 2017 Dec; 47(12):2090-2100. PubMed ID: 28762472
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Periplocoside E inhibits experimental allergic encephalomyelitis by suppressing interleukin 12-dependent CCR5 expression and interferon-gamma-dependent CXCR3 expression in T lymphocytes.
    Zhu YN; Zhong XG; Feng JQ; Yang YF; Fu YF; Ni J; Liu QF; Tang W; Zhao WM; Zuo JP
    J Pharmacol Exp Ther; 2006 Sep; 318(3):1153-62. PubMed ID: 16751252
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Endothelin-1 overexpression exacerbate experimental allergic encephalomyelitis.
    Guo Y; Chung SK; Siu CW; Kwan SC; Ho PW; Yeung PK; Chan KH
    J Neuroimmunol; 2014 Nov; 276(1-2):64-70. PubMed ID: 25205217
    [TBL] [Abstract][Full Text] [Related]  

  • 49. IFN-inducible protein 10/CXC chemokine ligand 10-independent induction of experimental autoimmune encephalomyelitis.
    Klein RS; Izikson L; Means T; Gibson HD; Lin E; Sobel RA; Weiner HL; Luster AD
    J Immunol; 2004 Jan; 172(1):550-9. PubMed ID: 14688366
    [TBL] [Abstract][Full Text] [Related]  

  • 50. IKKβ-mediated inflammatory myeloid cell activation exacerbates experimental autoimmune encephalomyelitis by potentiating Th1/Th17 cell activation and compromising blood brain barrier.
    Lee MJ; Bing SJ; Choi J; Jang M; Lee G; Lee H; Chang BS; Jee Y; Lee SJ; Cho IH
    Mol Neurodegener; 2016 Jul; 11(1):54. PubMed ID: 27450563
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Overexpression of glia maturation factor reinstates susceptibility to myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis in glia maturation factor deficient mice.
    Zaheer S; Wu Y; Sahu SK; Zaheer A
    Neurobiol Dis; 2010 Dec; 40(3):593-8. PubMed ID: 20696246
    [TBL] [Abstract][Full Text] [Related]  

  • 52. LRRC4 functions as a neuron-protective role in experimental autoimmune encephalomyelitis.
    Zhang Y; Li D; Zeng Q; Feng J; Fu H; Luo Z; Xiao B; Yang H; Wu M
    Mol Med; 2021 May; 27(1):44. PubMed ID: 33932995
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Therapeutic effect of the total saponin from Panax Japonicus on experimental autoimmune encephalomyelitis by attenuating inflammation and regulating gut microbiota in mice.
    Wang J; He L; Wang S; Zhao H; Chen J; Dong Y; Yasen S; Wang L; Zou H
    J Ethnopharmacol; 2023 Oct; 315():116681. PubMed ID: 37230280
    [TBL] [Abstract][Full Text] [Related]  

  • 54. CCR7 ligands are required for development of experimental autoimmune encephalomyelitis through generating IL-23-dependent Th17 cells.
    Kuwabara T; Ishikawa F; Yasuda T; Aritomi K; Nakano H; Tanaka Y; Okada Y; Lipp M; Kakiuchi T
    J Immunol; 2009 Aug; 183(4):2513-21. PubMed ID: 19625643
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Decoy receptor 3 ameliorates experimental autoimmune encephalomyelitis by directly counteracting local inflammation and downregulating Th17 cells.
    Chen SJ; Wang YL; Kao JH; Wu SF; Lo WT; Wu CC; Tao PL; Wang CC; Chang DM; Sytwu HK
    Mol Immunol; 2009 Dec; 47(2-3):567-74. PubMed ID: 19819554
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Arctigenin Suppress Th17 Cells and Ameliorates Experimental Autoimmune Encephalomyelitis Through AMPK and PPAR-γ/ROR-γt Signaling.
    Li W; Zhang Z; Zhang K; Xue Z; Li Y; Zhang Z; Zhang L; Gu C; Zhang Q; Hao J; Da Y; Yao Z; Kong Y; Zhang R
    Mol Neurobiol; 2016 Oct; 53(8):5356-66. PubMed ID: 26440666
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pertussis Toxin Inhibits Encephalitogenic T-Cell Infiltration and Promotes a B-Cell-Driven Disease during Th17-EAE.
    Maria Z; Turner E; Agasing A; Kumar G; Axtell RC
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33805762
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Th40 cells (CD4+CD40+ Tcells) drive a more severe form of Experimental Autoimmune Encephalomyelitis than conventional CD4 T cells.
    Vaitaitis GM; Yussman MG; Waid DM; Wagner DH
    PLoS One; 2017; 12(2):e0172037. PubMed ID: 28192476
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Sema4A is implicated in the acceleration of Th17 cell-mediated neuroinflammation in the effector phase.
    Koda T; Namba A; Kinoshita M; Nakatsuji Y; Sugimoto T; Sakakibara K; Tada S; Shimizu M; Yamashita K; Takata K; Ishikura T; Murata S; Beppu S; Kumanogoh A; Mochizuki H; Okuno T
    J Neuroinflammation; 2020 Mar; 17(1):82. PubMed ID: 32169103
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Blockade of CD47 ameliorates autoimmune inflammation in CNS by suppressing IL-1-triggered infiltration of pathogenic Th17 cells.
    Gao Q; Zhang Y; Han C; Hu X; Zhang H; Xu X; Tian J; Liu Y; Ding Y; Liu J; Wang C; Guo Z; Yang Y; Cao X
    J Autoimmun; 2016 May; 69():74-85. PubMed ID: 26994903
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 57.